Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sight Sciences (SGHT) Amortization of Deferred Charges (2020 - 2025)

Historic Amortization of Deferred Charges for Sight Sciences (SGHT) over the last 6 years, with Q3 2025 value amounting to $249000.0.

  • Sight Sciences' Amortization of Deferred Charges fell 3481.68% to $249000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $917000.0, marking a year-over-year increase of 2879.21%. This contributed to the annual value of $753000.0 for FY2024, which is 2263.84% up from last year.
  • According to the latest figures from Q3 2025, Sight Sciences' Amortization of Deferred Charges is $249000.0, which was down 3481.68% from $237000.0 recorded in Q2 2025.
  • In the past 5 years, Sight Sciences' Amortization of Deferred Charges ranged from a high of $382000.0 in Q3 2024 and a low of $74000.0 during Q2 2024
  • Moreover, its 5-year median value for Amortization of Deferred Charges was $170000.0 (2021), whereas its average is $181000.0.
  • In the last 5 years, Sight Sciences' Amortization of Deferred Charges tumbled by 5066.67% in 2024 and then surged by 22027.03% in 2025.
  • Over the past 5 years, Sight Sciences' Amortization of Deferred Charges (Quarter) stood at $170000.0 in 2021, then fell by 8.82% to $155000.0 in 2022, then increased by 4.52% to $162000.0 in 2023, then grew by 25.31% to $203000.0 in 2024, then increased by 22.66% to $249000.0 in 2025.
  • Its Amortization of Deferred Charges was $249000.0 in Q3 2025, compared to $237000.0 in Q2 2025 and $228000.0 in Q1 2025.